Assessment of Prolonged Safety and tOLerability of in Migraine Patients in a Long-term OpeN-label Study
Clinical trial NCT04084314 · COMPLETED
Trial details
- NCT number
- NCT04084314
- Sponsor
- Novartis Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2019-09-30
- Primary completion
- 2023-02-23
- Enrollment
- 701
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.